Evidence map›Paper›PMID 41124290›Full record

ArticlePLoS neglected tropical diseases2025

Entomological surveys and insecticide resistance in the dengue vector Aedes aegypti in Dakar, Senegal: First detection of the kdr mutation.

Ndeye Marie Sene, Shirley Nimo-Paintsil, Moussa Gaye, El Hadj Ndiaye, El Hadji Malick Ngom, Babacar Diouf, Faty Amadou Sy, Moussa Moise Diagne, Alioune Gaye, Diawo Diallo and 5 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ndeye Marie SeneMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Senegal.ORCID 0009-0000-3386-3003
Shirley Nimo-PaintsilUnited States of America Naval Medical Research Unit-EURAFCENT Ghana Detachment, Accra, Ghana.
Moussa GayeMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Senegal.
El Hadj NdiayeMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Senegal.
El Hadji Malick NgomMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Senegal.
Babacar DioufMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Senegal.
Faty Amadou SyMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Senegal.
Moussa Moise DiagnePôle de Virologie, Institut Pasteur de Dakar, Dakar, Senegal.
Alioune GayeMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Senegal.
Diawo DialloMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Senegal.
Ibrahima DiaMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Senegal.
Scott C WeaverWorld Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Samuel DadzieNoguchi Memorial Institute for Medical Research, Legon, Accra, Ghana.
James F HarwoodUnited States of America Naval Medical Research Unit-EURAFCENT Sigonella, Italy.
Mawlouth DialloMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Senegal.

Funding

West African Center for Emerging Infectious DiseasesU01AI151801 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Robert W Cross, Scott C Weaver · 2020 to 2026
$10.1M
NIAID NIH HHS U01 AI151801
6 · The paper itself

Abstract

Aedes aegypti is the primary vector of arboviruses in Senegal, yet this species is not typically targeted by routine vector control programs. Through entomological surveillance, we investigated over a one-year (2022-2023) the risk of arbovirus transmission in Dakar, Senegal, the spatial distribution of insecticide resistance and the underlying resistance mechanisms. Weekly ovitraps were deployed in 15 localities (10 per locality), and monthly adult mosquito collections were conducted in six localities. Arboviruses were detected in adult Ae. aegypti using Real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) and positive sample were sequenced for phylogenetic analysis to determine the genetic diversity. Blood-feeding preferences and resting behaviors were assessed, and WHO tube bioassays evaluated susceptibility to pyrethroids, organophosphates, and carbamates. Molecular screening targeted knockdown resistance (kdr) mutations (F1534C, V1016G/I, S989P). Ovitrap positivity peaked between August and October, coinciding with the rainy season. Ae. aegypti was detected in all surveyed localities, and dengue virus (DENV) was found in adult mosquitoes between September and December 2022, confirming active transmission risk. Females predominantly fed on humans and were found resting both indoors and outdoors. All tested populations were resistant to permethrin and bendiocarb, with suspected resistance to malathion. kdr mutations of F1534C (CC, FC), V1016G (VG), S989P (SP, and PP) were detected. These findings demonstrate a substantial entomological risk of arbovirus transmission in Dakar, characterized by high vector density, confirmed DENV infection, and widespread insecticide resistance. In this study, we detected three kdr mutations (F1534C, V1016G, and S989P), while previous studies in Senegal have documented metabolic resistance mechanisms. Together, these resistance mechanisms may compromise the efficacy of vector control strategies. Integrated vector management combining rational insecticide use, source reduction, and innovative control tools is recommended for sustainable Aedes-borne disease control in Senegal.

Indexed as

AedesInsecticide ResistanceInsecticidesMosquito VectorsAnimalsDengueDengue VirusFemaleHumansInsect ProteinsMutationPhylogenyPyrethrinsSenegalInsecticidesInsect ProteinsPyrethrins

Identifiers

PMID41124290
PMCPMC12561948

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.